MARKET

GLAXF

GLAXF

GSK PLC
OTCPK
22.77
NaN%
Closed 09:30 10/23 EDT
OPEN
--
PREV CLOSE
22.77
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
29.56
52 WEEK LOW
16.52
MARKET CAP
92.11B
P/E (TTM)
14.56
1D
5D
1M
3M
1Y
5Y
1D
Ionis Pharmaceuticals: Compelling Long-Term Commercial Upside
Seeking Alpha · 6h ago
Jemperli (dostarlimab-gxly) approved in US as first and only immunotherapy for adults with MSI-H/dMMR locally advanced rectal cancer
Barchart · 6d ago
Weekly Report: what happened at GLAXF last week (1012-1016)?
Weekly Report · 6d ago
Alector: Maintaining "Hold" ABC Platform Transition And GCase Partnership With Roche
Seeking Alpha · 6d ago
GSK: Maintaining Strong Buy For LAI HIV Sales Growth And Further Oncology Expansion
Seeking Alpha · 10/14 19:55
GSK plans more than 1,200 job cuts in Belgium
Seeking Alpha · 10/14 09:37
Weekly Report: what happened at GLAXF last week (1005-1009)?
Weekly Report · 10/12 09:57
GSK: The Gas Pedal Is Finally Down
Seeking Alpha · 10/07 14:45
More
About GLAXF
GSK plc is a United Kingdom-based biopharma company. The Company is focused on the science of the immune system and advanced technologies, investing in four core therapeutic areas-respiratory, immunology and inflammation; oncology; human immunodeficiency virus (HIV), and infectious diseases. Its segments include Commercial Operations and Research and Development. Its specialty medicines prevent and treat diseases, from asthma, cancer and HIV to autoimmune diseases like lupus. General medicines include inhalers for asthma and chronic obstructive pulmonary disease (COPD) to antibiotics. It also owns ozureprubart, a long-acting anti-immunoglobulin E (IgE) monoclonal antibody and HS235, a potential molecule for the treatment of pulmonary hypertension (PH). Its oncology portfolio also includes Zidesamtinib (NVL-520), neladalkib (NVL-655), and NVL-330. Its products include Anoro Ellipta, Apretude, Arexvy, Bexsero, Blenrep, Blujepa, Boostrix, Cervarix, Dovato, Efimosfermin, among others.

Webull offers GSK plc stock information, including OTCPK: GLAXF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GLAXF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GLAXF stock methods without spending real money on the virtual paper trading platform.